{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:56:11Z","timestamp":1768895771653,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s40257-022-00694-z","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T08:02:45Z","timestamp":1654329765000},"page":"591-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comment on: \u201cIs There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-\u03b1 Inhibitors?\u201d"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1361-4995","authenticated-orcid":false,"given":"Mafalda","family":"Pestana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-4739","authenticated-orcid":false,"given":"Margarida","family":"Brito Caldeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Cabete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,4]]},"reference":[{"issue":"1062","key":"694_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90(1062):216\u201320. https:\/\/doi.org\/10.1136\/postgradmedj-2013-131994.","journal-title":"Postgrad Med J"},{"key":"694_CR2","doi-asserted-by":"publisher","first-page":"204062231985164","DOI":"10.1177\/2040622319851640","volume":"10","author":"K Savage","year":"2019","unstructured":"Savage K, Flood K, Porter M, Kimball A. TNF-\u03b1 inhibitors in the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2019;10:204062231985164. https:\/\/doi.org\/10.1177\/2040622319851640.","journal-title":"Ther Adv Chronic Dis."},{"issue":"6","key":"694_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/jdv.13216","volume":"30","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Sobell JM, Zouboulis CC, et al. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study. J Eur Acad Dermatol Venereol. 2016;30(6):989\u201394. https:\/\/doi.org\/10.1111\/jdv.13216.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"694_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40257-020-00579-z","volume":"22","author":"T Abdalla","year":"2021","unstructured":"Abdalla T, Lowes MA, Kaur N, Micheletti RG, Steinhart AH, Alavi A. Is there a role for therapeutic drug monitoring in patients with hidradenitis suppurativa on tumor necrosis factor-\u03b1 inhibitors? Am J Clin Dermatol. 2021;22(2):139. https:\/\/doi.org\/10.1007\/s40257-020-00579-z.","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"694_CR5","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","volume":"155","author":"W Chen","year":"2019","unstructured":"Chen W, Chi C. Association of hidradenitis suppurativa with inflammatory bowel disease. JAMA Dermatol. 2019;155(9):1022\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2019.0891.","journal-title":"JAMA Dermatol"},{"key":"694_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-015-0018-8","author":"F Giudici","year":"2015","unstructured":"Giudici F, Maggi L, Santi R, et al. Perianal Crohn\u2019s disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy. 2015. https:\/\/doi.org\/10.1186\/s12948-015-0018-8.","journal-title":"Clin Mol Allergy."},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-106. https:\/\/doi.org\/10.1136\/gutjnl-2019-318484.","journal-title":"Gut"},{"issue":"1","key":"694_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MEG.0000000000001561","volume":"32","author":"N Plevris","year":"2020","unstructured":"Plevris N, Jenkinson P, Arnott I, Jones G, Lees C. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn\u2019s disease. Eur J Gastroenterol Hepatol. 2020;32(1):32\u20137. https:\/\/doi.org\/10.1097\/MEG.0000000000001561.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"694_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0001-7310(17)30007-8","volume":"107","author":"A Martorell","year":"2016","unstructured":"Martorell A, Caballero A, Gonz\u00e1lez Lama Y, et al. Manejo del paciente con hidradenitis supurativa. Actas Dermosifiliogr. 2016;107:32\u201342. https:\/\/doi.org\/10.1016\/S0001-7310(17)30007-8.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"694_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jaad.2019.09.071","volume":"82","author":"M Ghias","year":"2020","unstructured":"Ghias M, Johnston A, Kutner A, Micheletti R, Hosgood H, Cohen S. High-dose, high-frequency infliximab: a novel treatment paradigm for hidradenitis suppurativa. J Am Acad Dermatol. 2020;82(5):1094\u2013101. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.071.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00694-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00694-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00694-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:54:45Z","timestamp":1659113685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00694-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00694-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,4]]},"assertion":[{"value":"19 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors received no financial support for the authorship or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mafalda Pestana, Margarida Brito Caldeira, and Joana Cabete have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors contributed to the planning and design of the work. M.P. wrote the manuscript with input from all authors, who also read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}